David Smith

David Smith

Presidente presso THERACRYF PLC

Patrimonio netto: 2 M $ in data 30/09/2026

60 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Dr. David A. Smith is a Non-Executive Chairman at TheraCryf Plc, an Independent Non-Executive Director at Thalia Therapeutics Plc and a Non-Executive Chairman at SPARTA Biodiscovery Ltd. He is on the Board of Directors at Thalia Therapeutics Plc and Nextmune Laboratories Ltd. Dr. Smith was previously employed as a Chief Executive Officer & Executive Director by Avacta Group Plc, a Chief Executive Officer & Director by Avacta Life Sciences Ltd., and a Director-Institute of Molecular Biophysics by University of Leeds.
He also served on the board at TheraGenetics Ltd. He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Manchester.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
04/06/2025 1.565.100 ( 0,33% ) 1 M $ 30/09/2026
09/09/2026 36.212.888 ( 1,33% ) 86 549 $ 30/09/2026

Posizioni attive di David Smith

SocietàPosizioneInizio
THALIA THERAPEUTICS PLC Direttore/Membro del Consiglio 08/01/2025
THERACRYF PLC Presidente 19/02/2025
Presidente -
Direttore/Membro del Consiglio 06/02/2009

Precedenti posizioni note di David Smith

SocietàPosizioneFine
AVACTA GROUP PLC Fondatore 01/05/2024
Amministratore Delegato -
Direttore/Membro del Consiglio -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di David Smith

Formazione di David Smith

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

52

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. David Smith